Cite
HARVARD Citation
Liu, Y. et al. (2021). ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. Cancer science. 112 (7), pp. 2714-2727. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liu, Y. et al. (2021). ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. Cancer science. 112 (7), pp. 2714-2727. [Online].